Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness
Clinical trial NCT05603143 · TERMINATED
Trial details
- NCT number
- NCT05603143
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-05
- Primary completion
- 2023-11-07
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.